The next era of cell therapy

“...the next era of cell therapy will be defined less by isolated breakthroughs and more by integration.” Advanced cell therapy has entered a period of explosive growth. The past decade proved that engineered immune cells can cure diseases once considered untreatable. The next decade will determine whether those breakthroughs can overcome current limitations and mature into foundational pillars of medicine. We are now at a moment when biological possibility is no longer the primary constraint. Instead, the field must solve the intertwined challenges of manufacturing, delivery, safety, systems integration, and global scalability. Across the contributions in this edition, a unifying theme emerges: advanced cell therapy is evolving from a collection of extraordinary scientific achievements into an industrial, regulatory, and clinical ecosystem that must function as a coordinated whole.

Authors

Institutions

Publication Details

Journal
Cell and Gene Therapy Insights
Published
2026-02-25
DOI
https://doi.org/10.18609/cgti.2026.012
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The next era of cell therapy

Yu Cao
Cell and Gene Therapy Insights
CAR-T cell therapy research
article

The next era of cell therapy

Yu Cao
article en

Abstract

“...the next era of cell therapy will be defined less by isolated breakthroughs and more by integration.” Advanced cell therapy has entered a period of explosive growth. The past decade proved that engineered immune cells can cure diseases once considered untreatable. The next decade will determine whether those breakthroughs can overcome current limitations and mature into foundational pillars of medicine. We are now at a moment when biological possibility is no longer the primary constraint. Instead, the field must solve the intertwined challenges of manufacturing, delivery, safety, systems integration, and global scalability. Across the contributions in this edition, a unifying theme emerges: advanced cell therapy is evolving from a collection of extraordinary scientific achievements into an industrial, regulatory, and clinical ecosystem that must function as a coordinated whole.

Cell and Gene Therapy InsightsVol. 12(1)
Genex Systems (United States) (US)
Openalex Percentile: Top 41%
CAR-T cell therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.